-
Empagliflozin, CAS NO:864070-44-0
Chemical & Physical Properties
Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.
Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only.
-
![(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan；CAS:915095-89-5;Empagliflozin intermediate](//cdn.globalso.com/cheerour/915095-89-5-300x300.png)
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan；CAS:915095-89-5;Empagliflozin intermediate
high quaity with competitive price,also support on audit and documents
![(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan；CAS:915095-89-5;Empagliflozin intermediate](http://cdn.globalso.com/cheerour/915095-89-5-300x300.png)